Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 26.63 | 19.94 | 14.95 | 23.01 | 37.52 |
| Operating profit | -3.96 | -5.61 | -2.54 | -0.59 | 2.07 |
| Interest | 1.10 | 0.64 | 0.35 | 0.38 | 0.54 |
| Gross profit | -4.28 | -6.25 | -2.89 | -0.97 | 1.53 |
| EPS (Rs) | -1.19 | -2.31 | -2.84 | -0.49 | 0.06 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 0.77 | - | - | - | - |
| Stock adjustment | 2.24 | -1.21 | -1.90 | 2.92 | 1.63 |
| Raw material | 18.59 | 19.76 | 12.66 | 14.49 | 28.19 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.88 | 0.50 | 0.43 | 0.15 | 0.18 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 6.86 | 6.49 | 6.31 | 6.05 | 5.45 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.31 | 1.33 | 0.80 | 0.79 | 0.81 |
| Taxation | -1.37 | -0.02 | - | 0.12 | - |
| Net profit / loss | -4.22 | -7.72 | -4.03 | -0.70 | 0.09 |
| Extra ordinary item | - | -0.16 | -0.34 | 1.18 | -0.64 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 35.48 | 33.48 | 14.20 | 14.20 | 14.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -14.85 | -28.14 | -17.02 | -2.58 | 5.52 |
| GPM (%) | -15.63 | -31.32 | - | -4.23 | 4.08 |
| NPM (%) | -15.39 | -38.71 | - | -3.03 | 0.23 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis